Dual GIP & GLP-1 Agonists While Single GLP-1 RAs focus on one incretin pathway (the GLP-1 pathway), Dual GIP and GLP-1 agonists double down by also acting on another pathway involved in glucose regulation and energy balance
Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me...
Other Metabolic Benefits In the T2D trial, there were also dose-response reductions in HbA1c: retatrutide 12 mg reduced HbA1c by 2.16% at 36 weeks, corresponding to an estimated difference from dulaglutide 1.5 mg of -0.80% (95% CI: -1.16, -0.44)
We think youll find Quicksilver's designs to offer a unique blend of sonic strengths, excellent reliability, and superb value
Thanks for reading
Convergence with Combination Biology Dual and multi-agonist molecules combining GLP-1 activity with GIP and/or glucagon receptor activity are emerging and driving superior metabolic efficacy in clinical studies
